Login
$CDNA
$70.53 +$1.43 (2.07%) Close

$CDNA 8-K/A SEC Filings

Filed On Filing
16 Sep 2026 8-K/A: Completion of Acquisition or Disposition of Assets

The following unaudited pro forma condensed combined financial information gives effect to the acquisition of Naveris, Inc. (“Naveris”) by CareDx, Inc. (the “Company” or “CareDx”) pursuant to the Agreement and Plan of Merger (the “Merger...

23 Apr 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously disclosed in the Original Report, on February 24, 2026, the Company appointed Keith Kennedy, the Company’s previous Chief Operating Officer, as the Company’s Chief Financial Officer and Chief Operating Officer, effective as...

25 Feb 2026 8-K/A: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

Full Year 2025 Total Revenue of $380 Million Increased 14% Year-Over-Year

24 Jun 2020 8-K/A: Submission of Matters to a Vote of Security Holders
10 Jun 2020 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year
27 May 2016 8-K/A: Financial Statements and Exhibits

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support